Pre-endothelialization of a tissue-engineered vascular graft before implantation aims to prevent thrombosis and immunoreactions. This work demonstrates a standardized cultivation process to build a confluent monolayer with human aortal endothelial cells on xenogenous scaffolds. Pre-tested dynamic cultivation conditions in flow slides with pulsatile flow (1 Hz) representing arterial wall conditions were transferred to a newly designed multi-featured rotational bioreactor system. The medium was thickened with 1% methyl cellulose simulating a non-Newtonian fluid comparable to blood. Computational fluid dynamics was used to estimate the optimal volume flow and medium distribution inside the bioreactor chamber for defined wall-near shear stress ...
The Cardiovascular diseases (CVDs) continue to be the leading cause of morbidity and mortality world...
The aim of the study was to compare the behavior of seeded cells on synthetic and natural aortic val...
Abstract Tissue engineered vascular grafts (TEVG) are potentially clear from ethical and epidemiolog...
Multiple efforts have been made to develop small-diameter tissue engineered vascular grafts using a ...
Objective: Previous tissue engineering approaches to create small caliber vascular grafts have been ...
The generation of a living protective layer at the luminal surface of cardiovascular devices, compos...
The creation of thick cardiac tissue for scar replacement therapy following myocardial infarction (M...
Conventional synthetic vascular grafts require ongoing anticoagulation, and autologous venous grafts...
Tissue engineering has gained attention as an alternative approach for developing small diameter tis...
peer-reviewedExisting synthetic vascular grafts have unacceptably high failure rates when replacing...
Background: Tissue engineering represents a promising new method for treating heart valve diseases. ...
AbstractObjectives:to develop a perfusion system for culturing human endothelial cells on small-diam...
The development of vascularized scaffolds remains one of the major challenges in tissue engineering,...
Prosthetic vascular grafting is largely successful in patients undergoing surgical intervention for ...
The Cardiovascular diseases (CVDs) continue to be the leading cause of morbidity and mortality world...
The aim of the study was to compare the behavior of seeded cells on synthetic and natural aortic val...
Abstract Tissue engineered vascular grafts (TEVG) are potentially clear from ethical and epidemiolog...
Multiple efforts have been made to develop small-diameter tissue engineered vascular grafts using a ...
Objective: Previous tissue engineering approaches to create small caliber vascular grafts have been ...
The generation of a living protective layer at the luminal surface of cardiovascular devices, compos...
The creation of thick cardiac tissue for scar replacement therapy following myocardial infarction (M...
Conventional synthetic vascular grafts require ongoing anticoagulation, and autologous venous grafts...
Tissue engineering has gained attention as an alternative approach for developing small diameter tis...
peer-reviewedExisting synthetic vascular grafts have unacceptably high failure rates when replacing...
Background: Tissue engineering represents a promising new method for treating heart valve diseases. ...
AbstractObjectives:to develop a perfusion system for culturing human endothelial cells on small-diam...
The development of vascularized scaffolds remains one of the major challenges in tissue engineering,...
Prosthetic vascular grafting is largely successful in patients undergoing surgical intervention for ...
The Cardiovascular diseases (CVDs) continue to be the leading cause of morbidity and mortality world...
The aim of the study was to compare the behavior of seeded cells on synthetic and natural aortic val...
Abstract Tissue engineered vascular grafts (TEVG) are potentially clear from ethical and epidemiolog...